{"schemaVersion":"1.0","precedentGraphVersion":"RPG-0.6","answerAsOf":"2026-08-12","clusterCount":1,"memberEdgeCount":5,"clusters":[{"id":"precedent:future-pcac-cohort","slug":"future-pcac-cohort","peplystId":"peplyst:precedent:future-pcac-cohort:v1","title":"Future PCAC review cohort","comparisonAxis":"process_stage","sharedFeature":"FDA announced future PCAC consideration; the meeting date and full compound-specific briefing record remain pending.","transferLimit":"Being in the same future-review cohort predicts neither committee advice nor final FDA action and does not establish equivalence among members.","memberSlugs":["ll-37","ghk-cu","dihexa-acetate","melanotan-ii","peg-mgf"],"memberNames":["LL-37","GHK-Cu","Dihexa acetate","Melanotan II","PEG-MGF"],"sourceUrls":["https://www.fda.gov/advisory-committees/pharmacy-compounding-advisory-committee/meeting-pharmacy-compounding-advisory-committee"],"confidence":94,"answerAsOf":"2026-08-12","reviewGate":"human_review_required_for_substantive_change"}]}